LB Pharmaceuticals Inc Common Stock LBRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.65M+328% | $8.48M+2,156% | $2.42M-77.3% | $2.42M— | $3.42M— | ||
| $7.46M+148% | $5.39M+4.3% | $2.83M-47.8% | $2.44M— | $3.01M— | ||
| $22.1M+244% | $13.87M+150% | $5.25M-67.4% | $4.86M— | $6.43M— | ||
| $22.1M+244% | $13.87M+150% | $5.25M-67.4% | $4.86M— | $6.43M— | ||
| $2.85M+1,108% | $2.8M+840% | $707K+84.1% | $177K— | $236K— | ||
| $3.05M+172% | $2.4M+412% | $1.69M-11.1% | $0— | $1.12M— | ||
| -$19.05M-259% | -$11.47M-126% | -$3.56M+74.9% | -$4.87M— | -$5.31M— | ||
| $0— | $1K0.0% | $0— | $0— | $0— | ||
| -$19.05M-259% | -$11.47M-126% | -$3.56M+74.9% | -$4.87M+82.4% | -$5.31M+67.3% | ||
| -$0.67+95.5% | —— | -$0.61+98.5% | —— | -$14.79— | ||
| -$0.67+95.5% | —— | -$0.61+98.5% | —— | -$14.79— | ||
| 28.2M+7,772% | 8M+2,146% | 5.8M+1,517% | —— | 358.8K— | ||
| 28.2M+7,772% | 8M+2,146% | 5.8M+1,517% | —— | 358.8K— | ||
| $200K-74.0% | —— | $983K-3.2% | —— | $768K— | ||
| $28.24M+7,772% | $5.85M+1,730,653% | $5.81M+1,517% | —— | $358.78K— | ||
| -$19.05M-259% | -$11.47M-126% | -$3.56M+74.9% | -$4.87M— | -$5.31M— | ||
| -$18.97M-263% | -$11.39M-126% | -$3.48M+75.5% | -$4.79M— | -$5.23M— | ||
| -$18.97M-263% | -$11.39M-126% | -$3.48M+75.5% | -$4.79M— | -$5.23M— | ||
| -$19.05M-259% | -$11.47M-126% | -$3.56M+74.9% | -$4.87M— | -$5.31M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is LB Pharmaceuticals Inc Common Stock profitable?
- LB Pharmaceuticals Inc Common Stock is not currently profitable: it reported a net loss of $39.0M over the trailing twelve months.
- What is LB Pharmaceuticals Inc Common Stock's earnings per share?
- LB Pharmaceuticals Inc Common Stock's diluted EPS over the trailing twelve months is $-30.07.
- Where does LB Pharmaceuticals Inc Common Stock's income statement data come from?
- Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.